Errors in delivery of cancer genetics services: implications for practice
- PMID: 20806621
Errors in delivery of cancer genetics services: implications for practice
Abstract
Advances in genetics have prompted recommendations that all healthcare providers perform genetic counseling and testing. Some experts are concerned about potential negative outcomes from cancer genetic testing performed without genetic counseling by certified genetics professionals. We report a national series of cases illustrating negative outcomes of cancer genetic testing performed without counseling by a qualified provider. Three major patterns emerged from analysis of these cases: 1) Wrong genetic test ordered, 2) Genetic test results misinterpreted, and 3) Inadequate genetic counseling. Negative outcomes included unnecessary prophylactic surgeries, unnecessary testing, psychosocial distress, and false reassurance resulting in inappropriate medical management.
Conclusion: With the complexities of cancer genetic counseling and testing, it may be unrealistic to expect all clinicians to provide these services. A more realistic approach is better provider education and a framework in which healthcare providers identify patients who would benefit from a referral to a certified genetic counselor or experienced cancer genetics professional.
Similar articles
-
Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.Cancer J. 2012 Jul-Aug;18(4):303-9. doi: 10.1097/PPO.0b013e3182609490. Cancer J. 2012. PMID: 22846730 Review.
-
Adverse Events in Genetic Testing: The Fourth Case Series.Cancer J. 2019 Jul/Aug;25(4):231-236. doi: 10.1097/PPO.0000000000000391. Cancer J. 2019. PMID: 31335384 Review.
-
Adverse events in cancer genetic testing: the third case series.Cancer J. 2014 Jul-Aug;20(4):246-53. doi: 10.1097/PPO.0000000000000057. Cancer J. 2014. PMID: 25098283
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.N Engl J Med. 1997 Mar 20;336(12):823-7. doi: 10.1056/NEJM199703203361202. N Engl J Med. 1997. PMID: 9062090
Cited by
-
The current state of cancer genetic counseling access and availability.Genet Med. 2016 Apr;18(4):410-2. doi: 10.1038/gim.2015.98. Epub 2015 Aug 6. Genet Med. 2016. PMID: 26248009
-
A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.Alzheimers Dement. 2015 Oct;11(10):1222-30. doi: 10.1016/j.jalz.2014.10.014. Epub 2014 Dec 9. Alzheimers Dement. 2015. PMID: 25499536 Free PMC article. Clinical Trial.
-
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine.Healthcare (Basel). 2016 Jan 8;4(1):6. doi: 10.3390/healthcare4010006. Healthcare (Basel). 2016. PMID: 27417594 Free PMC article. Review.
-
A Case for Inclusion of Genetic Counselors in Cardiac Care.Cardiol Rev. 2016 Mar-Apr;24(2):49-55. doi: 10.1097/CRD.0000000000000081. Cardiol Rev. 2016. PMID: 26186385 Free PMC article. Review.
-
Breaking barriers: fostering equitable access to pediatric genomics through innovative care models and technologies.Pediatr Res. 2025 Mar;97(4):1261-1268. doi: 10.1038/s41390-025-03859-8. Epub 2025 Jan 16. Pediatr Res. 2025. PMID: 39821137 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical